Education, Research & Positions
SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells
SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma Summary SIRPα blockade enhances immunotherapy effectiveness in hepatocellular carcinoma (HCC) by targeting a specific subset of myeloid cells. These myeloid cells, which Read More
